Mary E. Norton, MD (she/her/hers)

Professor, Dept of Obstetrics, Gynecology & Reproductive Sciences
University of California, San Francisco
San Francisco, CA, United States

Dr. Mary Norton is a perinatologist and clinical geneticist, and is a Professor in the Department of Obstetrics, Gynecology and Reproductive Sciences, of Pediatrics, and of Surgery at the University of California, San Francisco. She is Vice Chair of Clinical and Translational Genetics, and holds the David E. Thorburn, M.D. and Kate McKee Thorburn Endowed Chair in Perinatal Medicine and Genetics. She completed her residency in Obstetrics and Gynecology at Tufts University Affiliated Hospitals, and her fellowship in Maternal-Fetal Medicine and Clinical Genetics at the University of California, San Francisco. She is currently co-Director of the Fetal Treatment Program, and co-Director of the UCSF Center for Maternal-Fetal Precision Medicine. She is also Past President of the Perinatal Quality Foundation (PQF), Past President of the Society for Maternal-Fetal Medicine (SMFM), and past Chair of the Publications Committee of the SMFM. Her clinical and research interests include genetic testing and its application to prenatal screening and diagnosis. She focuses on the unique aspects of translating new genetic and genomic technologies into improved care for pregnant women and their fetuses. Much of her research has involved cell free DNA screening and implementation into practice, as well as patient and provider education regarding prenatal genetics’ generally, and cfDNA specifically. Her work with SMFM has involved guidelines for perinatal care and she has been involved with writing guidelines regarding cfDNA screening. She has also been involved with patient and provider education initiatives through PQF.

Disclosure information not submitted.

Presentation(s):

• Screening and Diagnostic Genetic Test

  Monday, February 6, 2023
  3:30 PM – 4:20 PM

• PW - President’s Workshop on Developing an Optimal Maternal-Fetal Medicine Ultrasound Practice - Day 1

  Tuesday, February 7, 2023
  8:00 AM – 5:00 PM

• Integration of genetics into ultrasound practice

  Tuesday, February 7, 2023
  1:00 PM – 1:20 PM

• Breakout Group 4: Current and emerging approaches to managing the pregnant person with obstetric ultrasound - Day1 Discussion

  Tuesday, February 7, 2023
  2:00 PM – 5:30 PM

• PW - President’s Workshop on Developing an Optimal Maternal-Fetal Medicine Ultrasound Practice - Day 2

  Wednesday, February 8, 2023
  8:30 AM – 12:00 PM

• 56 - Patient Perspectives on the Utility and Impact of Prenatal Exome Sequencing

  Friday, February 10, 2023
  2:45 PM – 3:00 PM

• 57 - High fetal fraction on cell-free fetal DNA screening: is it associated with adverse perinatal outcomes?

  Friday, February 10, 2023
  3:00 PM – 3:15 PM

• 58 - Postnatal phenotyping after negative prenatal exome sequencing for fetal anomalies

  Friday, February 10, 2023
  3:15 PM – 3:30 PM